PureTech Health (PRTC) EPS (Basic) (2023 - 2025)

PureTech Health (PRTC) reported EPS (Basic) of -$9.18 for Q2 2025, up 100.0% year-over-year from -$4.59 in Q2 2024, and down 5490.68% quarter-over-quarter from -$0.16 in Q4 2024.

PureTech Health (PRTC) EPS (Basic) (2023 - 2025) Analysis & Trends

PureTech Health (PRTC) has 3 years of EPS (Basic) data on file, last reported at -$9.18 in Q2 2025.

  • EPS (Basic) for Q2 2025 came in at -$9.18, up 100.0% year-over-year; the trailing twelve-month figure through Dec 2025 was -$278496.0 (changed 0.0% YoY), and the FY2025 annual result was -$0.46, down 319.05% from the prior year.
  • EPS (Basic) declined to -$9.18 in Q2 2025 per PRTC's latest filing, from -$0.16 in the prior quarter.
  • Over five years, EPS (Basic) peaked at -$0.09 in Q4 2023 and troughed at -$278486.7 in Q2 2024.
  • A 3-year average of -$69624.0 and a median of -$4.67 in 2024 frame the typical range for EPS (Basic).
  • The sharpest annual moves came in 2024 and 2025: EPS (Basic) plunged 78.49% in 2024, then jumped 100.0% in 2025.
  • A 3-year view of EPS (Basic) shows it stood at -$0.09 in 2023, then tumbled by 78.49% to -$0.16 in 2024, then tumbled by 5490.68% to -$9.18 in 2025.
  • Business Quant data shows PRTC's EPS (Basic) at -$9.18 in Q2 2025, -$0.16 in Q4 2024, and -$278486.7 in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -0.68
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 3.06
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.00
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 0.00
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 0.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 0.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 4.06
9 Abivax 91.96 Bn 91.96 Bn - -0.06
10 PureTech Health 86.36 Mn -190.94 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2025 -9.18
Dec 31, 2024 -0.16
Jun 30, 2024 -278,486.67
Dec 31, 2023 -0.09